154 related articles for article (PubMed ID: 15756676)
21. Regulation of multidrug resistance by MGr1-antigen in gastric cancer cells.
Sun L; Shi Y; Guo C; Yao L; Lin T; Du J; Han Q; Han Y; Fan D
Tumour Biol; 2006; 27(1):27-35. PubMed ID: 16340247
[TBL] [Abstract][Full Text] [Related]
22. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR.
Du J; Pan Y; Shi Y; Guo C; Jin X; Sun L; Liu N; Qiao T; Fan D
Int J Cancer; 2005 Jan; 113(2):213-20. PubMed ID: 15386405
[TBL] [Abstract][Full Text] [Related]
23. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
24. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
25. Investigation of transcriptional gene silencing and mechanism induced by shRNAs targeted to RUNX3 in vitro.
Feng XZ; He XS; Zhuang YZ; Luo Q; Jiang JH; Yang S; Tang XF; Liu JL; Chen T
World J Gastroenterol; 2008 May; 14(19):3006-14. PubMed ID: 18494051
[TBL] [Abstract][Full Text] [Related]
26. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo.
Yan LH; Wang XT; Yang J; Kong FB; Lian C; Wei WY; Luo W; Xie YB; Xiao Q
J Cell Biochem; 2014 Jan; 115(1):34-41. PubMed ID: 24038122
[TBL] [Abstract][Full Text] [Related]
27. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.
Ito K; Liu Q; Salto-Tellez M; Yano T; Tada K; Ida H; Huang C; Shah N; Inoue M; Rajnakova A; Hiong KC; Peh BK; Han HC; Ito T; Teh M; Yeoh KG; Ito Y
Cancer Res; 2005 Sep; 65(17):7743-50. PubMed ID: 16140942
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between Runx3 gene expression and its DNA methylation in gastric cancer].
Gao N; Chen WC; Cen JN
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):361-4. PubMed ID: 18953836
[TBL] [Abstract][Full Text] [Related]
29. ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting
Tan B; Li Y; Zhao Q; Fan L; Wang D
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126848
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori CagA inhibits the expression of Runx3 via Src/MEK/ERK and p38 MAPK pathways in gastric epithelial cell.
Liu Z; Xu X; Chen L; Li W; Sun Y; Zeng J; Yu H; Chen C; Jia J
J Cell Biochem; 2012 Mar; 113(3):1080-6. PubMed ID: 22266963
[TBL] [Abstract][Full Text] [Related]
31. Runx3-/- gastric epithelial cells differentiate into intestinal type cells.
Fukamachi H; Ito K; Ito Y
Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer.
Kitajima Y; Ohtaka K; Mitsuno M; Tanaka M; Sato S; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jan; 19(1):197-202. PubMed ID: 18097595
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers.
Goel A; Arnold CN; Tassone P; Chang DK; Niedzwiecki D; Dowell JM; Wasserman L; Compton C; Mayer RJ; Bertagnolli MM; Boland CR
Int J Cancer; 2004 Dec; 112(5):754-9. PubMed ID: 15386381
[TBL] [Abstract][Full Text] [Related]
34. [The overexpression and significance of MKP-1 in oxygen-deprived gastric cancer cell line SGC7901].
Liu CJ; Shi YQ; Han ZY; Xue Y; Pan YL; Shen HQ; Du JP; Han S; Qiao TD; Fan DM
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):306-11. PubMed ID: 15059515
[TBL] [Abstract][Full Text] [Related]
35. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
Han YX; Liang DY
Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
[TBL] [Abstract][Full Text] [Related]
36. Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway.
Zhang ZD; Li Y; Fan Q; Zhao B; Tan B; Zhao XF
Neoplasma; 2014; 61(6):627-37. PubMed ID: 25150310
[TBL] [Abstract][Full Text] [Related]
37. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.
Wada M; Yazumi S; Takaishi S; Hasegawa K; Sawada M; Tanaka H; Ida H; Sakakura C; Ito K; Ito Y; Chiba T
Oncogene; 2004 Mar; 23(13):2401-7. PubMed ID: 14743205
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
[TBL] [Abstract][Full Text] [Related]
39. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistantgastric cancer cells to cisplatin.
Mao Z; Bian G; Sheng W; He S; Yang J; Dong X
Oncol Rep; 2013 Nov; 30(5):2288-96. PubMed ID: 23982423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]